Rick Haas
Bijzonder hoogleraar Radiotherapie, in het bijzonder van bot- en wekedelentumoren
- Naam
- Prof.dr. R.L.M. Haas
- Telefoon
- +31 71 526 9111
- r.l.m.haas@lumc.nl
- ORCID iD
- null
Namens de Stichting het Nederlands Kanker Instituut is Rick L. M. Haas bijzonder hoogleraar Radiotherapie. In 2021 zal hij voorzitter zijn van de Connective Tissue Oncology Society (CTOS). Hij is Board Member van de European Muskulo-Skeletal Oncology Society (EMSOS)
Namens de Stichting het Nederlands Kanker Instituut is Rick L. M. Haas bijzonder hoogleraar Radiotherapie. In 2021 zal hij voorzitter zijn van de Connective Tissue Oncology Society (CTOS). Hij is Board Member van de European Muskulo-Skeletal Oncology Society (EMSOS)
Radiotherapie in het bijzonder van bot en weke delen tumoren
De leerstoel heeft als naam meegekregen: “Radiotherapie in het bijzonder van bot en weke delen tumoren”. Hoewel de groep van sarcomen een heterogene verzameling van verschillende tumoren behelst, wordt in de huidige preoperatieve praktijk een uniform schema van 25 x 2 Gy in 5 weken aan iedereen gegeven.
De onderzoekslijnen die Haas met zijn leerstoel en met zijn collega’s uit de sarcomen tumorwerkgroep gaat uitzetten betreffen vooral het zoeken naar (1) individualisatie op basis van specifieke sarcoomsoorten hierin, (2) het zoeken naar variaties in fractiegrootte en totaal dosis en (3) het exploreren van het toevoegen van medicamenten om de bestraling effectiever te maken (radiosensitisering).
Het belang van dit onderzoek is het zo beperkt mogelijk houden van de behandel belasting van patiënten met behoud van effectiviteit.
Wetenschappelijke carrière
Rick L.M. Haas heeft zijn opleiding Geneeskunde afgerond aan de Vrije Universiteit te Amsterdam in 1988. Aan deze universiteit is hij ook gepromoveerd in 2006 op het proefschrift getiteld: “Low dose radiotherapy in indolent lymphomas, enough is enough”. Zijn specialisatie tot radiotherapeut heeft hij volbracht in het Antoni van Leeuwenhoek Huis te Amsterdam in 1997, waar hij sindsdien als staflid is blijven werken. Sinds 2017 heeft hij ook een gastaanstelling bij de afdeling radiotherapie van het LUMC. Hij hoopt in 2021 zijn oratie te kunnen houden.
Bijzonder hoogleraar Radiotherapie, in het bijzonder van bot- en wekedelentumoren
- Faculteit Geneeskunde
- Divisie 4
- Radiotherapie
- Kousi, E.; Messiou, C.; Miah, A.; Orton, M.; Haas, R.; Thway, K.; Hopkinson, G.; Zaidi, S.; Smith, M.; Barquin, E.; Moskovic, E.; Fotiadis, N.; Strauss, D.; Hayes, A. & Schmidt, M.A. (2021), Descriptive analysis of MRI functional changes occurring during reduced dose radiotherapy for myxoid liposarcomas, British Journal of Radiology 94(1126).
- Hagenmaier HSF, van Beeck AGK, Haas RL, van Praag VM, van Bodegom-Vos L, van der Hage JA, Krol S, Speetjens FM, Cleven AHG, Navas A, Kroon HM, Moeri-Schimmel RG, Leyerzapf NAC & van de Sande MAJ (2021), The Influence of Personalised Sarcoma Care (PERSARC) Prediction Modelling on Clinical Decision Making in a Multidisciplinary Setting, Sarcoma 2021: 1--6.
- Lansu, J.; Houdt, W.J. van; Langevelde, K. van; Ende, P.L.A. van den; Graaf, W.T.A. van der; Schrage, Y.; , H. van boven; Scholten, A.N. & Haas, R.L. (2021), Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas (vol 158, pg 33, 2021), Radiotherapy & Oncology 163: 245-245.
- Wiltink, L.M.; Haas, R.L.M.; Gelderblom, H. & Sande, M.A.J. van de (2021), Treatment strategies for metastatic soft tissue sarcomas, Cancers 13(7).
- Lam, M.B.; Baldini, E.H.; Reijers, S.J.M.; Haas, R.L. & DeLaney, T.F. (2021), Role of radiation therapy for newly diagnosed retroperitoneal sarcoma, Current Treatment Options in Oncology 22(9).
- Haas, R.L.; Floot, B.G.J.; Scholten, A.N.; Graaf, W.T.A. van der; Houdt, W. van; Schrage, Y.; Ven, M. van de; Bovee, J.V.M.G.; Coevorden, F. van & Vens, C. (2021), Cellular Radiosensitivity of Soft Tissue Sarcoma, Radiation Research 196(1): 23-30.
- Lansu, J.; Braam, P.M.; Werkhoven, E. van; Scholten, A.N.; Schrage, Y.; Houdt, W.J. van; Langevelde, K. van & Haas, R.L. (2021), A moderate dose of preoperative radiotherapy may improve resectability in myxoid liposarcoma, European Journal of Surgical Oncology 47(10): 2633-2639.
- Acem, I.; Smit, M.M.; Verhoef, C.; Houdt, W.J. van; Haas, R.L.; Hage, J.A. van der; Grunhagen, D.J. & Sande, M.A.J. van de (2021), Management of soft tissue sarcomas in extremities, Annals of Surgical Oncology 28.
- Gennaro, N.; Reijers, S.; Bruining, A.; Messiou, C.; Haas, R.; Colombo, P.; Bodalal, Z.; Beets-Tan, R.; Houdt, W. van & Graaf, W.T.A. van der (2021), Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: where do we stand?, Critical Reviews in Oncology/Hematology 160.
- Callegaro, D.; Raut, C.P.; Ng, D.; Strauss, D.C.; Honore, C.; Stoeckle, E.; Bonvalot, S.; Haas, R.L.; Vassos, N.; Conti, L.; Gladdy, R.A.; Fairweather, M.; Houdt, W. van; Schrage, Y.; Coevorden, F. van; Rutkowski, P.; Miceli, R.; Gronchi, A. & Swallow, C.J. (2021), Has the outcome for patients who undergo resection of primary retroperitoneal sarcoma changed over time? A study of time trends during the past 15 years, Annals of Surgical Oncology 28(3): 1700-1709.
- Lansu, J.; Bovee, J.V.M.G.; Braam, P.; , H. van boven; Flucke, U.; Bonenkamp, J.J.; Miah, A.B.; Zaidi, S.H.; Thway, K.; Bruland, O.S.; Baldini, E.H.; Jebsen, N.L.; Scholten, A.N.; Ende, P.L.A. van den; Krol, A.D.G.; Ubbels, J.F.; Hage, J.A. van der; Werkhoven, E. van; Klomp, H.M.; Graaf, W.T.A. van der; Coevorden, F. van; Schrage, Y.; Houdt, W.J. van & Haas, R.L. (2021), Dose reduction of preoperative radiotherapy in myxoid liposarcoma, JAMA Oncology 7(1).
- Lansu, J.; Houdt, W.J. van; Langevelde, K. van; Ende, P.L.A. van den; Graaf, W.T.A. van der; Schrage, Y.; , H. van boven; Scholten, A.N. & Haas, R.L. (2021), Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas, Radiotherapy & Oncology 158: 33-39.
- Haas, R.L.M.; Stelmes, J.J.; Zaffaroni, F.; Clementel, E.; Bar Deroma, R.; Pechoux, C. le; Litiere, S.; Marreaud, S.; Alyamani, N.; Andratschke, N.; Sangalli, C.; Chung, P.W.M.; Miah, A.; Hurkmans, C.; Gronchi, A.; Bovee, J.V.M.G.; Gelderblom, H.; Kasper, B.; Weber, D. & Bonvalot, S. (2021), Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: results from the 62092-22092 STRASS trial., Journal of Clinical Oncology 39(15).
- Meekeren, M. van; Bovee, J.V.M.G.; Coevorden, F. van; Houdt, W. van; Schrage, Y.; Koenen, A.M.; Miah, A.B.; Zaidi, S.; Hayes, A.J.; Thway, K.; Krol, S.; Fiocco, M.; Gelderblom, H.; Steeghs, N. & Haas, R.L. (2021), Revision of: a phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma, Acta Oncologica 60(12): 1557-1564.
- Lansu, J.; Houdt, W.J. van; Langevelde, K. van; Ende, P.L.A. van den; Graaf, W.T.A. van der; Schrage, Y.; , H. van boven; Scholten, A.N. & Haas, R.L. (2021), Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas, Radiotherapy & Oncology 158.
- Demetri, G.D.; Antonescu, C.R.; Bjerkehagen, B.; Bovee, J.V.M.G.; Boye, K.; Chacon, M.; Tos, A.P. dei; Desai, J.; Fletcher, J.A.; Gelderblom, H.; George, S.; Gronchi, A.; Haas, R.L.; Hindi, N.; Hohenberger, P.; Joensuu, H.; Jones, R.L.; Judson, I.; Kang, Y.K.; Kawai, A.; Lazar, A.J.; Cesne, A. le; Maestro, R.; Maki, R.; Martin, J.; Patel, S.; Penault-Llorca, F.; Raut, C.P.; Rutkowski, P.; Safwat, A.; Sbaraglia, M.; Schaefer, I.M.; Shen, L.; Serrano, C.; Schoffski, P.; Stacchiotti, S.; Hall, K.S.; Tap, W.D.; Thomas, D.M.; Trent, J.; Valverde, C.; Graaf, W.T.A. van der; Mehren, M. von; Wagner, A.; Wardelmann, E.; Naito, Y.; Zalcberg, J. & Blay, J.Y. (2020), Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network, Annals of Oncology 31(11): 1506-1517.
- Haas, R.L.; Walraven, I.; Lecointe-Artzner, E.; Houdt, W.J. van; Strauss, D.; Schrage, Y.; Hayes, A.J.; Raut, C.P.; Fairweather, M.; Baldini, E.H.; Gronchi, A.; Rosa, L. de; Griffin, A.M.; Ferguson, P.C.; Wunder, J.; Sande, M.A.J. van de; Krol, A.D.G.; Skoczylas, J.; Sangalli, C. & Stacchiotti, S. (2020), Extrameningeal solitary fibrous tumors—surgery alone or surgery plus perioperative radiotherapy, Cancer 126(13).
- Haas, R.L.; Walraven, I.; Lecointe-Artzner, E.; Houdt, W.J. van; Scholten, A.N.; Strauss, D.; Schrage, Y.; Hayes, A.J.; Raut, C.P.; Fairweather, M.; Baldini, E.H.; Gronchi, A.; Rosa, L. de; Griffin, A.M.; Ferguson, P.C.; Wunder, J.; Sande, M.A.J. van de; Krol, A.D.G.; Skoczylas, J.; Brandsma, D.; Doglietto, F.; Sangalli, C. & Stacchiotti, S. (2020), Management of meningeal solitary fibrous tumors/hemangiopericytoma; surgery alone or surgery plus postoperative radiotherapy?, Acta Oncologica.
- Bonvolot, S.; Gronchi, A.; Pechoux, C. le; Swallow, C.J.; Strauss, D.; Meeus, P.; Coevorden, F. van; Stoldt, S.; Stoeckle, E.; Rutkowski, P.; Rastrelli, M.; Rout, C.P.; Hompes, D.; Paoli, A. de; Sangalli, C.; Honore, C.; Chung, P.; Miah, A.; Blay, J.Y.; Fiore, M.; Stelmes, J.J.; Tos, A.P. dei; Baldini, E.H.; Litiere, S.; Marreaud, S.; Gelderblom, H. & Haas, R.L. (2020), Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial, The Lancet Oncology 21(10): 1366-1377.
- Ng, D.; Callegaro, D.; Raut, C.; Strauss, D.; Honore, C.; Stoeckle, E.; Bonvalot, S.; Haas, R.; Houdt, W. van; Rutkowski, P.; Schrage, Y.; Fiore, M. & Swallow, C. (2020), Predictors of Grossly Incomplete Resection in Primary Retroperitoneal Sarcoma (RPS), Annals of Surgical Oncology 27(SUPPL 1): S211-S212.
- Smolle, M.A.; Sande, M. van de; Callegaro, D.; Wunder, J.; Hayes, A.; Leitner, L.; Bergovec, M.; Tunn, P.U.; Praag, V. van; Fiocco, M.; Panotopoulos, J.; Willegger, M.; Windhager, R.; Dijkstra, S.P.D.; Houdt, W.J. van; Riedl, J.M.; Stotz, M.; Gerger, A.; Pichler, M.; Stoger, H.; Liegl-Atzwanger, B.; Smolle, J.; Andreou, D.; Leithner, A.; Gronchi, A.; Haas, R.L. & Szkandera, J. (2020), Individualizing follow-up strategies in high-grade soft tissue sarcoma with flexible parametric competing risk regression models, Cancers 12(1).
- Haas, R.L.; Walraven, I.; Lecointe-Artzner, E.; Houdt, W.J. van; Strauss, D.; Schrage, Y.; Hayes, A.J.; Raut, C.P.; Fairweather, M.; Baldini, E.H.; Gronchi, A.; Rosa, L. de; Griffin, A.M.; Ferguson, P.C.; Wunder, J.; Sande, M.A.J. van de; Krol, A.D.G.; Skoczylas, J.; Sangalli, C. & Stacchiotti, S. (2020), Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy, Cancer 126(13): 3002-3012.
- Tos, A.P. dei; Bonvalot, S. & Haas, R. (2020), Evolution in the management of soft tissue sarcoma: classification, surgery and use of radiotherapy, Expert Review of Anticancer Therapy 20: 3-13.
- Hirschmann, A.; Praag, V.M. van; Haas, R.L.; Sande, M.A.J. van de & Bloem, J.L. (2020), Can we use MRI to detect clinically silent recurrent soft-tissue sarcoma?, European Radiology 30(9): 4724-4733.
- Haas, R.L.; Walraven, I.; Lecointe-Artzner, E.; Houdt, W.J. van; Scholten, A.N.; Strauss, D.; Schrage, Y.; Hayes, A.J.; Raut, C.P.; Fairweather, M.; Baldini, E.H.; Gronchi, A.; Rosa, L. de; Griffin, A.M.; Ferguson, P.C.; Wunder, J.; Sande, M.A.J. van de; Krol, A.D.G.; Skoczylas, J.; Brandsma, D.; Doglietto, F.; Sangalli, C. & Stacchiotti, S. (2020), Management of meningeal solitary fibrous tumors/hemangiopericytoma; surgery alone or surgery plus postoperative radiotherapy?, Acta Oncologica.
- Haas, R.L.M.; Trama, A. & Stacchiotti, S. (2020), Reply to Incidence of extrameningeal solitary fibrous tumors and novel therapeutic approaches in the treatment of solitary fibrous tumors: A call for a combination therapy.
- Page, M.J.; O'Connor, D.A.; Malek, M.; Haas, R.; Beaton, D.; Huang, H.M.; Ramiro, S.; Richards, P.; Voshaar, M.J.H.; Shea, B.; Verhagen, A.P.; Whittle, S.L.; Windt, D.A. van der; Gagnier, J.J.; Buchbinder, R. & OMERACT Shoulder Core Set (2019), Patients' experience of shoulder disorders: a systematic review of qualitative studies for the OMERACT Shoulder Core Domain Set, Rheumatology 58(8): 1410-1421.
- Bonvalot, S.; Gronchi, A.; Pechoux, C. le; Swallow, C.J.; Strauss, D.C.; Meeus, P.; Coevorden, F. van; Stoldt, S.; Stoeckle, E.; Rutkowski, P.; Sangalli, C.; Honore, C.; Rastrelli, M.; Raut, C.; Chung, P.; Fiore, M.; Litiere, S.; Marreaud, S.; Gelderblom, H. & Haas, R.L.M. (2019), STRASS (EORTC 62092): A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma., Journal of Clinical Oncology 37(15).
- Jong, Y. de; Ingola, M.; Briaire-de Bruijn, I.H.; Kruisselbrink, A.B.; Venneker, S.; Palubeckaite, I.; Heijs, B.P.A.M.; Cleton-Jansen, A.M.; Haas, R.L.M. & Bovee, J.V.M.G. (2019), Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes, Clinical Sarcoma Research 9.
- Haas, R.L.M.; Bonvalot, S.; Miceli, R.; Strauss, D.C.; Swallow, C.J.; Hohenberger, P.; Coevorden, F. van; Rutkowski, P.; Callegaro, D.; Hayes, A.J.; Honore, C.; Fairweather, M.; Gladdy, R.; Jakob, J.; Szacht, M.; Fiore, M.; Chung, P.W.; Houdt, W.J. van; Raut, C.P. & Gronchi, A. (2019), Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group, Cancer 125(8): 1290-1300.
- Houdt, W.J. van; Raut, C.P.; Bonvalot, S.; Swallow, C.J.; Haas, R. & Gronchi, A. (2019), New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration, Current Opinion in Oncology 31(4): 310-316.
- Haas, R.L. & Sande, M.A.J. van de (2019), Considering sarcoma staging systems and their implications to personalized care, Chinese clinical oncology 8.
- Soomers, V.; Husson, O.; Desar, I.M.E.; Strauss, D.; Haas, R.L.; Verhoef, K.; Sande, M.A.J. van de; Been, L.; Parry, M.C.; Poll-Franse, L.V. van de & Graaf, W.T. van der (2019), Assessing quality of life and experiences of diagnostic trajectories of sarcoma patients: The QUEST study protocol, Annals of Oncology 30.
- Houdt, W.J. van; Raut, C.P.; Bonvalot, S.; Swallow, C.J.; Haas, R. & Gronchi, A. (2019), New research strategies in retroperitoneal sarcoma, Current Opinion in Oncology 31(4).
- Lansu, J.; Groenewegen, J.; Coevorden, F. van; Houdt, W. van; Akkooi, A.C.J. van; , H. van boven; Sande, M. van de; Verheij, M. & Haas, R.L. (2019), Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue Sarcomas, EJSO - European Journal of Surgical Oncology 45(4): 684-690.
- Kostine, M.; Briaire-de Bruijn, I.H.; Cleven, A.H.G.; Vervat, C.; Corver, W.E.; Schilham, M.W.; Beelen, E. van; , H. van boven; Haas, R.L.; Italiano, A.; Cleton-Jansen, A.M. & Bovee, J.V.M.G. (2018), Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies, OncoImmunology 7(2).
- Haas, R.L. & Szkandera, J. (2018), ASO Author Reflections: Benefit of Adjuvant Radiotherapy for Clinical Outcome in Patients with Soft Tissue Sarcoma, Annals of Surgical Oncology 25: 924-925.
- Tos, A.P. dei; Bonvalot, S. & Haas, R. (2018), The key role of pathology, surgery and radiotherapy in the initial management of soft tissue sarcoma, Future Oncology 14(10).
- Haas, R.L.; Walraven, I.; Lecointe-Artzner, E.; Scholten, A.N.; Houdt, W.J. van; Griffin, A.M.; Ferguson, P.C.; Miah, A.B.; Zaidi, S.; DeLaney, T.F.; Chen, Y.L.; Spalek, M.; Krol, S.D.G.; Moeri-Schimmel, R.G.; Sande, M.A.J. van de; Sangalli, C. & Stacchiotti, S. (2018), Radiation Therapy as Sole Management for Solitary Fibrous Tumors (SFT): A Retrospective Study From the Global SFT Initiative in Collaboration With the Sarcoma Patients EuroNet, International Journal of Radiation Oncology - Biology - Physics 101(5): 1226-1233.
- Haas, R.L. (2018), Preoperative radiotherapy in soft tissue sarcoma: from general guidelines to personalized medicine, Chinese clinical oncology 7(4).
- Raman, S.; Ding, K.Y.; Chow, E.; Meyer, R.M.; Linden, Y.M. van der; Roos, D.; Hartsell, W.F.; Hoskin, P.; Wu, J.S.Y.; Nabid, A.; Haas, R.; Wiggenraad, R.; Babington, S.; Demas, W.F.; Wilson, C.F.; Wong, R.K.S.; Zhu, L.T. & Brundage, M. (2018), Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases, Quality of Life Research 27(4): 1089-+.
- Haas, R. (2018), Managing Extremity Soft Tissue Sarcoma Patients: Surgery Alone or in Combination with Radiotherapy? An Editorial on the Paper by Fiore et al., Annals of Surgical Oncology 25(6): 1461-1462.
- Haas, R.L.; Baldini, E.H.; Chung, P.W.; Coevorden, F. van & DeLaney, T.F. (2018), Radiation therapy in retroperitoneal sarcoma management, Journal of Surgical Oncology 117(1): 93-98.
- Sargos, P.; Charleux, T.; Haas, R.L.; Michot, A.; Llacer, C.; Moureau-Zabotto, L.; Vogin, G.; Pechoux, C. le; Verry, C.; Ducassou, A.; Delannes, M.; Mervoyer, A.; Wiazzane, N.; Thariat, J.; Sunyach, M.P.; Benchalal, M.; Laredo, J.D.; Kind, M.; Gillon, P. & Kantor, G. (2018), Pre- and postoperative radiotherapy for extremity soft tissue sarcoma: Evaluation of inter-observer target volume contouring variability among French sarcoma group radiation oncologists, Cancer Radiothérapie 22(2): 131-139.
- MacNeill, A.J.; Gronchi, A.; Miceli, R.; Bonvalot, S.; Swallow, C.J.; Hohenberger, P.; Coevorden, F. van; Rutkowski, P.; Callegaro, D.; Hayes, A.J.; Honore, C.; Fairweather, M.; Cannell, A.; Jakob, J.; Haas, R.L.; Szacht, M.; Fiore, M.; Casali, P.G.; Pollock, R.E.; Barretta, F.; Raut, C.P. & Strauss, D.C. (2018), Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma A Report From the Transatlantic RPS Working Group, Annals of Surgery 267(5): 959-964.
- Haas, R.L.; Gronchi, A.; Sande, M.A.J. van de; Baldini, E.H.; Gelderblom, H.; Messiou, C.; Wardelmann, E. & Cesne, A. le (2018), Perioperative Management of Extremity Soft Tissue Sarcomas, Journal of Clinical Oncology 36(2): 118-+.
- Wiltink, L.M.; Nout, R.A.; Fiocco, M.; Creutzberg, C.L. & Marijnen, C.A.M. (2017), Reply to M. Wissing et al., Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
- MacNeill, A.J.; Miceli, R.; Strauss, D.C.; Bonvalot, S.; Hohenberger, P.; Coevorden, F. van; Rutkowski, P.; Callegaro, D.; Hayes, A.J.; Honore, C.; Fairweather, M.; Cannell, A.; Jakob, J.; Haas, R.L.; Szacht, M.; Fiore, M.; Casali, P.G.; Pollock, R.E.; Raut, C.P.; Gronchi, A. & Swallow, C.J. (2017), Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group, Cancer 123(11): 1971-1978.
- Ahlen, J.; Ahuja, N.; Antbacka, R.; Bagaria, S.; Blay, J.Y.; Bonvalot, S.; Callegaro, D.; Canter, R.J.; Cardona, K.; Casali, P.G.; Colombo, C.; Tos, A.P.D.; Paoli, A. de; Desai, A.; Dickson, B.C.; Eilber, F.C.; Fiore, M.; Fletcher, C.D.; Ford, S.J.; Gelderblom, H.J.; Gonzalez, R.; Grignani, G.; Grignol, V.; Gronchi, A.; Haas, R.L.; Hayes, A.J.; Hartmann, W.; Henzler, T.; Hohenberger, P.; Italiano, A.; Jakob, J.; Jones, R.L.; Judson, I.; Kane, J.M.; Lahat, G.; MacNeill, A.J.; Maestro, R.; Messiou, C.; Meeus, P.; Miceli, R.; Mullen, J.T.; Nessim, C.; Pennacchioli, E.; Pillarisetty, V.G.; Pollock, R.E.; Quagliuolo, V.; Radaelli, S.; Raut, C.P.; Rutkowski, P.; Sandrucci, S.; Schrage, Y.M.; Sicklick, J.K.; Smith, M.J.; Stacchiotti, S.; Stoeckle, E.; Strauss, D.C.; Swallow, C.J.; Tseng, W.; Wardelmann, E.; Coevorden, F. van; Houdt, W.J. van; Wasif, N. & Trans-Atlantic RPS Working Grp (2017), Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group (vol 23, pg 3531, 2016), Annals of Surgical Oncology 24: S688-S689.
- Ahlen, J.; Ahuja, N.; Antbacka, R.; Bagaria, S.; Blay, J.Y.; Bonvalot, S.; Callegaro, D.; Canter, R.J.; Cardona, K.; Casali, P.G.; Colombo, C.; Tos, A.P. dei; Paoli, A. de; Desai, A.; Dickson, B.C.; Eilber, F.C.; Fiore, M.; Fletcher, C.D.; Ford, S.J.; Gelderblom, H.J.; Gonzalez, R.; Grignani, G.; Grignol, V.; Gronchi, A.; Haas, R.L.; Hayes, A.J.; Hartmann, W.; Henzler, T.; Hohenberger, P.; Italiano, A.; Jakob, J.; Jones, R.L.; Judson, I.; Kane, J.M.; Lahat, G.; MacNeill, A.J.; Maestro, R.; Messiou, C.; Meeus, P.; Miceli, R.; Mullen, J.T.; Nessim, C.; Pennacchioli, E.; Pillarisetty, V.G.; Pollock, R.E.; Quagliuolo, V.; Radaelli, S.; Raut, C.P.; Rutkowski, P.; Sandrucci, S.; Schrage, Y.M.; Sicklick, J.K.; Smith, M.J.; Stacchiotti, S.; Stoeckle, E.; Strauss, D.C. & Trans-Atlantic RPS Working Grp (2016), Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group, Annals of Surgical Oncology 23(11): 3531-3540.
- Messiou, C.; Bonvalot, S.; Gronchi, A.; Vanel, D.; Meyer, M.; Robinson, P.; Morosi, C.; Bloem, J.L.; Terrier, P.H.; Lazar, A.; Pechoux, C. le; Wardelman, E.; Winfield, J.M.; Boulet, B.; Bovee, J. & Haas, R.L. (2016), Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC - STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging, European Journal of Cancer 56: 37-44.
- Wardelmann, E.; Haas, R.L.; Bovee, J.V.M.G.; Terrier, P.; Lazar, A.; Messiou, C.; LePechoux, C.; Hartmann, W.; Collin, F.; Fisher, C.; Mechtersheimer, G.; DeiTos, A.P.; Stacchiotti, S.; Jones, R.L.; Gronchi, A. & Bonvalot, S. (2016), Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting, European Journal of Cancer 53: 84-95.
- Gronchi, A.; Strauss, D.C.; Miceli, R.; Bonvalot, S.; Swallow, C.J.; Hohenberger, P.; Coevorden, F. van; Rutkowski, P.; Callegaro, D.; Hayes, A.J.; Honore, C.; Fairweather, M.; Cannell, A.; Jakob, J.; Haas, R.L.; Szacht, M.; Fiore, M.; Casali, P.G.; Pollock, R.E. & Raut, C.P. (2016), Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group, Annals of Surgery 263(5): 1002-1009.
- Tiong, S.S.; Dickie, C.; Haas, R.L. & O'Sullivan, B. (2016), The role of radiotherapy in the management of localized soft tissue sarcomas, Cancer biology & medicine 13(3): 373-383.
- Raut, C.P.; Miceli, R.; Strauss, D.C.; Swallow, C.J.; Hohenberger, P.; Coevorden, F. van; Rutkowski, P.; Fiore, M.; Callegaro, D.; Casali, P.G.; Haas, R.L.; Hayes, A.J.; Honore, C.; Cannell, A.J.; Jakob, J.; Szacht, M.; Fairweather, M.; Pollock, R.E.; Bonvalot, S. & Gronchi, A. (2016), External validation of a multi-institutional retroperitoneal sarcoma nomogram, Cancer 122(9): 1417-1424.
- Gronchi, A.; Haas, R.L. & Bonvalot, S. (2016), Cancer registries and randomised clinical trials in rare tumours: At the two extremes of daily clinical practice, European Journal of Cancer 64: 113-115.
- Blay, J.Y.; Bertuzzi, A.; Bielack, S.; Bjerkehagen, B.; Bonvalot, S.; Boukovinas, I.; Bruzzi, P.; Tos, A.P. dei; Dileo, P.; Eriksson, M.; Fedenko, A.; Ferrari, A.; Ferrari, S.; Gelderblom, H.; Grimer, R.J.; Gronchi, A.; Haas, R.L.; Hall, K.S.; Hohenberger, P.; Issels, R.; Joensuu, H.; Judson, I.; Cesne, A. le; Litiere, S.; Martin-Broto, J.; Merimsky, O.; Montemurro, M.; Morosi, C.; Picci, P.; Ray-Coquard, I.; Reichardt, P.; Rutkowski, P.; Schlemmer, M.; Stacchiotti, S.; Torri, V.; Trama, A.; Coevorden, F. van; Graaf, W. van der; Vanel, D.; Wardelmann, E.; Casali, P.G. & ESMO European Sarcoma Network Work (2015), Gastrointestinal Stromal Tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii21, 2014), Annals of Oncology 26: V174-V175.
- Stacchiotti, S.; Sommer, J.; Ares, C.; Blay, J.Y.; Bolle, S.; Boriani, S.; Capanna, R.; Casali, P.G.; Debus, J.; DeLaney, T.F.; Doglietto, F.; Flanagan, A.M.; Fossati, P.; Froelich, S.; Gelderblom, H.; Grimer, R.; Gronchi, A.; Haas, R.L.M.; Hohenberger, P.; Hornicek, F.J.; Jeys, L.; Kasper, B.; Keulen, H.; Krengli, M.; Leithner, A.; Martin-Broto, J.; Morosi, C.; Nicolai, P.; Norum, O.J.; Peul, W.C.; Pilotti, S.; Radaelli, S.; Rutkowski, P.; Scheipl, S.; Tamborini, E.; Torri, V.; Uhl, M.; Vanel, D.; Vleggeert-Lankamp, C.; Weber, D.C. & Chordoma Global Consensus Grp (2015), Building a global consensus approach to chordoma: a position paper from the medical and patient community, Lancet Oncology 16(2).
- Blay, J.Y.; Bertuzzi, A.; Bielack, S.; Bjerkehagen, B.; Bonvalot, S.; Boukovinas, I.; Bruzzi, P.; Tos, A.P. dei; Dileo, P.; Eriksson, M.; Fedenko, A.; Ferrari, A.; Ferrari, S.; Gelderblom, H.; Grimer, R.J.; Gronchi, A.; Haas, R.L.; Hall, K.S.; Hohenberger, P.; Issels, R.; Joensuu, H.; Judson, I.; Cesne, A. le; Litiere, S.; Martin-Broto, J.; Merimsky, O.; Montemurro, M.; Morosi, C.; Picci, P.; Ray-Coquard, I.; Reichardt, P.; Rutkowski, P.; Schlemmer, M.; Stacchiotti, S.; Torri, V.; Trama, A.; Coevorden, F. van; Graaf, W. van der; Vanel, D.; Wardelmann, E.; Casali, P.G. & ESMO European Sarcoma Network Work (2015), Soft Tissue and Visceral Sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii102, 2014), Annals of Oncology 26: V175-V176.
- Bellera, C.A.; Penel, N.; Ouali, M.; Bonvalot, S.; Casali, P.G.; Nielsen, O.S.; Delannes, M.; Litiere, S.; Bonnetain, F.; Dabakuyo, T.S.; Benjamin, R.S.; Blay, J.Y.; Bui, B.N.; Collin, F.; Delaney, T.F.; Duffaud, F.; Filleron, T.; Fiore, M.; Gelderblom, H.; George, S.; Grimer, R.; Grosclaude, P.; Gronchi, A.; Haas, R.; Hohenberger, P.; Issels, R.; Italiano, A.; Jooste, V.; Krarup-Hansen, A.; Pechoux, C. le; Mussi, C.; Oberlin, O.; Patel, S.; Piperno-Neumann, S.; Raut, C.; Ray-Coquard, I.; Rutkowski, P.; Schuetze, S.; Sleijfer, S.; Stoeckle, E.; Glabbeke, M. van; Woll, P.; Gourgou-Bourgade, S. & Mathoulin-Pelissier, S. (2015), Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials), Annals of Oncology 26(5): 865-872.
- Blay, J.Y.; Bertuzzi, A.; Bielack, S.; Bjerkehagen, B.; Bonvalot, S.; Boukovinas, I.; Bruzzi, P.; Tos, A.P. dei; Dileo, P.; Eriksson, M.; Fedenko, A.; Ferrari, A.; Ferrari, S.; Gelderblom, H.; Grimer, R.J.; Gronchi, A.; Haas, R.L.; Hall, K.S.; Hohenberger, P.; Issels, R.; Joensuu, H.; Judson, I.; Cesne, A. le; Litiere, S.; Martin-Broto, J.; Merimsky, O.; Montemurro, M.; Morosi, C.; Picci, P.; Ray-Coquard, I.; Reichardt, P.; Rutkowski, P.; Schlemmer, M.; Stacchiotti, S.; Torri, V.; Trama, A.; Coevorden, F. van; , G.W. van der; Vanel, D.; Wardelmann, E.; Casali, P.G. & ESMO European Sarcoma Network Work (2015), Bone Sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii113, 2014), Annals of Oncology 26: V176-V177.
- Haas, R.L.M.; Gelderblom, H.; Sleijfer, S.; , H.H. van boven; Scholten, A.; Dewit, L.; Borst, G.; Hage, J. van der; Kerst, J.M.; Nout, R.A.; Hartgrink, H.H.; Pree, I. de; Verhoef, C.; Steeghs, N. & Coevorden, F. van (2015), A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities, Acta Oncologica 54(8): 1195-1201.
- Baas, P.; Fennell, D.; Kerr, K.M.; Schil, P.E. van; Haas, R.L.; Peters, S. & ESMO Guidelines Comm (2015), Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(aEuro), Annals of Oncology 26: V31-V39.
- Baldini, E.H.; Bosch, W.; Abrams, R.A.; Roberge, D.; Olsen, J.R.; Haas, R.L.; Catton, C.N.; Indelicato, D.J.; DeLaney, T.F. & Wang, D. (2014), Retroperitoneal Sarcoma (RPS) Target Volume and Organ at Risk (OAR) Contour Delineation Agreement Among RTOG Sarcoma Radiation Oncologists, International Journal of Radiation Oncology - Biology - Physics 90: S116-S117.
- Vreeze, R.S.A. de; Jong, D. de; Koops, W.; Nederlof, P.M.; Ariaens, A.; Haas, R.L. & Coevorden, F. van (2011), Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis, International Journal of Cancer 128(4): 778-786.
- Vreeze, R.S.A. de; Jong, D. de; Nederlof, P.M.; Ariaens, A.; Tielen, I.H.G.; Frenken, L.; Haas, R.L. & Coevorden, F. van (2010), Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience, Annals of Surgical Oncology 17(3): 686-693.
- Vreeze, R.S.A. de; Jong, D. de; Tielen, I.H.G.; Ruijter, H.J.; Nederlof, P.M.; Haas, R.L. & Coevorden, F. van (2009), Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis, Modern Pathology 22(2): 223-231.
- Uitterhoeve, L.; Duppen, J.; Linden, Y. van der; Haas, R.; Olofsen-van Acht, M.; Terhaard, C.; Nout, R.; Zwijnenburg, E.; Wiegman, E.; Hurkmans, C.; Kolkman-Deurloo, I.K. & Marijnen, C. (2008), VARIATION IN DELINEATION OF THE GTV, CTV AND PTV BETWEEN THE TRAINING INSTITUTES FOR RADIATION ONCOLOGISTS IN THE NETHERLANDS, Radiotherapy and Oncology 88: S118-S118.
- van Sandick J. W., Kappers I., Baas P., Haas R. L. & Klomp H. M. (2008), Surgical treatment in the management of malignant pleural mesothelioma: A single institution's experience, Annals of Surgical Oncology 15(6): 1757-1764.
- de Vreeze R. S., de Jong D., Nederlof P. M., Haas R. L. & van Coevorden F. (2008), Primary retroperitoneal myxoid liposarcoma & em;a non existing disease? An immunohistochemical and molecular biologic analysis, Journal of Clinical Oncology 26(15).
- de Vreeze Ronald S. A., de Jong Daphne, Haas Rick L., Stewart Fiona & van Coevorden Frits (2008), EFFECTIVENESS OF RADIOTHERAPY IN MYXOID SARCOMAS IS ASSOCIATED WITH A DENSE VASCULAR PATTERN, International Journal of Radiation Oncology - Biology - Physics 72(5): 1480-1487.
- Knoops L, Haas RL, de Kemp S, Broeks A, van 't Veer LJ & de Jong D (2005), Low dose radiation induces a highly effective p53 response and rapid tumor regression in follicular lymphoma., Blood 106(11): 107A-107A.